Penumbra (NYSE:PEN) today announced a collaboration with the Veterans Health Administration (VHA) Office of Healthcare Innovation and Learning (OHIL). The collaboration covers testing, co-developing and implementing rehabilitative healthcare solutions through virtual reality (VR). Building on Penumbra’s REAL y-Series technology, the collaboration focuses on developing targeted therapy tools. These tools address the most critical rehabilitation needs […]
Penumbra
Penumbra grows sales 8% in Q4
Penumbra (NYSE:PEN) this week posted fourth-quarter results that beat the overall consensus on Wall Street. The Alameda, California-based company — maker of interventional devices for vascular and neuro therapies — reported profits of $3.9 million, or 10¢ per share, on sales of $221.2 million, for the three months ended Dec. 31, 2022. Sales were up 8.43% […]
FDA clears Lightning Flash thrombectomy system from Penumbra
Penumbra (NYSE:PEN) announced today that it received FDA clearance for the Lightning Flash mechanical thrombectomy system. Alameda, California-based Penumbra also initiated the launch for the system. The company called Lightning Flash “the most advanced and powerful mechanical thrombectomy system on the market.” Lightning Flash features the company’s novel Lightning intelligent aspiration technology with dual-clot detection […]
Penumbra launches VR-based rehab platform
Penumbra (NYSE:PEN) announced today that it launched a full-body, non-tethered immersive healthcare offering for rehabilitation. Alameda, California–based Penumbra designed its REAL y-Series product with lower and upper body sensors. They allow clinicians to track full-body movement and progress in real-time. By expanding its virtual reality-based immersive healthcare platform, Penumbra plans to support a broad range […]
Penumbra launches RED reperfusion catheters in Europe
Penumbra (NYSE:PEN) announced today that it received the CE mark for its RED reperfusion catheter and began its European launch. Alameda, California-based Penumbra designed its RED reperfusion catheter for the removal of all clot types in acute ischemic stroke (AIS) patients. Recent data presented by the company demonstrated successful revascularization using the RED system. Get […]
Data backs Penumbra’s catheters for stroke care
Penumbra (NYSE:PEN) announced today that initial data support the use of its RED reperfusion catheters and the Penumbra System. Alameda, California-based Penumbra presented results from the initial Insight Registry for the RED reperfusion catheters and the sub-analyses of the Complete study for the Penumbra system at the 2022 World Federation of Interventional and Therapeutic Neuroradiology […]
Penumbra posts mixed-bag Q4 results, grows sales 22%
Penumbra (NYSE:PEN) this week posted fourth-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Alameda, California-based company reported losses of -$24.6 million, or -66¢ per share, on sales of $204 million for the three months ended Dec. 31, 2021, for a sales growth of 22.24% compared with Q4 2020. Get […]
Data shows safety and strong performance for Penumbra’s Indigo CAT RX catheter
Penumbra (NYSE:PEN) announced today that the Cheetah clinical study for its Indigo CAT RX catheter met its primary endpoint. Alameda, California-based Penumbra’s Indigo catheter system demonstrated high rates of blood clot removal, blood flow restoration and myocardial perfusion in conjunction with percutaneous coronary intervention (PCI) in patients with high thrombus burden. The company presented the […]
Penumbra beats The Street in Q3, grows sales 25%
Penumbra (NYSE:PEN) posted third-quarter results this week that beat the overall consensus on Wall Street. The Alameda, California-based company reported profits of $8.85 million, or 24¢ per share, on sales of $190.1 million for the three months ended Sept. 30, for a sales growth of 25.84% compared with Q3 2020. Get the full story on our […]
MedTech 100 roundup: Hot streak comes to slight halt
After several weeks of high-level performance, the medtech industry saw its first dip in a while over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 13) at 117.92 points, marking a –1.2% dip from the 119.41-point tally a week prior […]
Penumbra sales grow 75% in Q2
Penumbra (NYSE:PEN) posted second-quarter results this week that beat the overall consensus on Wall Street. The Alameda, Calif.–based vascular conditions device company reported profits of $9.2 million, or 25¢ per share, on sales of $184.3 million for the three months ended June 30, for a sales growth of 75.3% compared with Q2 2020. Get the full […]
